在卵巢癌患者中开发和验证一种瘤特异性死亡预测名录:一个队列研究
Zhiwei Nie1, Min Xu2, Lin Shi1
1Department of Ultrasound, The Fourth People's Hospital of Zhenjiang, Zhenjiang, China.
Gland surgery
|October 27, 2025
概括
这项研究开发了一种使用对比增强超声波 (CEUS) 参数来预测卵巢癌死亡率的诺米克图. 该模型准确地识别了风险因素,如缩速度峰值 (PSV) 和第三阶段,改善了卵巢癌的预后工具.
科学领域:
- 在瘤学瘤学.
- 医疗成像医学成像
- 放射学 放射学是一门学科.
背景情况:
- 卵巢癌的死亡率很高,需要改进预后工具.
- 来自对比增强超声波 (CEUS) 的定量参数提供了一个有希望的,准确的和可重复的方法来预测患者的结果.
- 目前对卵巢癌的预后工具是有限的.
研究的目的:
- 开发一种用于卵巢癌患者瘤结果的诺莫格拉姆预测模型.
- 利用对比增强超声波 (CEUS) 的定量参数进行预后评估.
主要方法:
- 357名卵巢癌患者 (培训组) 和153名患者 (验证组) 的回顾性分析.
- 所有患者都接受了初级细胞削减手术,并被随访了5年.
- 在幸存者和非幸存者之间比较临床特征和CEUS定量参数.
主要成果:
- 死亡的独立风险因素包括缩速度峰值 (PSV),第三阶段,差异化不良和.
- 达到高峰的时间 (TTP) 已成为预防死亡的保护因素.
- 诺米图实现了高精度,ROC曲线下的面积在训练集中为0.948,在验证集中为0.860.
结论:
- 基于CEUS定量参数的开发名录显示出在预测卵巢癌预后方面具有良好的疗效和可靠性.
- 这种工具可以帮助分层患者和指导治疗策略.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K


